APO Research
Talk to an analyst

APO RESEARCH · REPORT

Filgrastim Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Filgrastim Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026180 pages

Choose your research edition.

Industry ResearchFilgrastim Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgrastim Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Filgrastim Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgrastim Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgrastim Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Filgrastim Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Filgrastim Injection include Teva Pharmaceuticals, Novartis AG, Pfizer, Amgen Inc and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Filgrastim Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Filgrastim Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Filgrastim Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Filgrastim Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Filgrastim Injection Segment by Company

Teva Pharmaceuticals

Novartis AG

Pfizer

Amgen Inc

Accord Healthcare

Filgrastim Injection Segment by Type

300mcg/0.5mL (Prefilled Syringe)

300mcg/mL (vial)

480mcg/0.8mL (Prefilled Syringe)

480mcg/1.6 mL (vial)

Filgrastim Injection Segment by Application

Adult Use

Pediatric Use

Geriatric Use

Filgrastim Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgrastim Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Filgrastim Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Filgrastim Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Filgrastim Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Filgrastim Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Filgrastim Injection Industry Trends Table 2. Filgrastim Injection Industry Drivers Table 3. Filgrastim Injection Industry Opportunities and Challenges Table 4. Filgrastim Injection Industry Restraints Table 5. Global Filgrastim Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Filgrastim Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Filgrastim Injection Sales by Manufacturers (K L) & (2021-2026) Table 8. Global Filgrastim Injection Sales Market Share by Manufacturers Table 9. Global Filgrastim Injection Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global Filgrastim Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Filgrastim Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Filgrastim Injection Manufacturers, Product Type & Application Table 13. Global Filgrastim Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Filgrastim Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 300mcg/0.5mL (Prefilled Syringe) Table 17. Major Manufacturers of 300mcg/mL (vial) Table 18. Major Manufacturers of 480mcg/0.8mL (Prefilled Syringe) Table 19. Major Manufacturers of 480mcg/1.6 mL (vial) Table 20. Global Filgrastim Injection Sales by Type 2021 VS 2025 VS 2032 (K L) Table 21. Global Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 22. Global Filgrastim Injection Sales by Type (2027-2032) & (K L) Table 23. Global Filgrastim Injection Sales Market Share by Type (2021-2026) Table 24. Global Filgrastim Injection Sales Market Share by Type (2027-2032) Table 25. Global Filgrastim Injection Revenue by Type 2021 VS 2025 VS 2032 (K L) Table 26. Global Filgrastim Injection Revenue by Type (2021-2026) & (K L) Table 27. Global Filgrastim Injection Revenue by Type (2027-2032) & (K L) Table 28. Global Filgrastim Injection Revenue Market Share by Type (2021-2026) Table 29. Global Filgrastim Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Adult Use Table 31. Major Manufacturers of Pediatric Use Table 32. Major Manufacturers of Geriatric Use Table 33. Global Filgrastim Injection Sales by Application 2021 VS 2025 VS 2032 (K L) Table 34. Global Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 35. Global Filgrastim Injection Sales by Application (2027-2032) & (K L) Table 36. Global Filgrastim Injection Sales Market Share by Application (2021-2026) Table 37. Global Filgrastim Injection Sales Market Share by Application (2027-2032) Table 38. Global Filgrastim Injection Revenue by Application 2021 VS 2025 VS 2032 (K L) Table 39. Global Filgrastim Injection Revenue by Application (2021-2026) & (K L) Table 40. Global Filgrastim Injection Revenue by Application (2027-2032) & (K L) Table 41. Global Filgrastim Injection Revenue Market Share by Application (2021-2026) Table 42. Global Filgrastim Injection Revenue Market Share by Application (2027-2032) Table 43. Global Filgrastim Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 44. Global Filgrastim Injection Sales by Region (2021-2026) & (K L) Table 45. Global Filgrastim Injection Sales Market Share by Region (2021-2026) Table 46. Global Filgrastim Injection Sales Forecasted by Region (2027-2032) & (K L) Table 47. Global Filgrastim Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 49. North America Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 50. North America Filgrastim Injection Sales by Country (2027-2032) & (K L) Table 51. Europe Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 52. Europe Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 53. Europe Filgrastim Injection Sales by Country (2027-2032) & (K L) Table 54. Asia Pacific Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 55. Asia Pacific Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 56. Asia Pacific Filgrastim Injection Sales by Country (2027-2032) & (K L) Table 57. South America, Middle East and Africa Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 58. South America, Middle East and Africa Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 59. South America, Middle East and Africa Filgrastim Injection Sales by Country (2027-2032) & (K L) Table 60. Global Filgrastim Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Filgrastim Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Filgrastim Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Filgrastim Injection Revenue Market Share by Region (2021-2026) Table 64. Global Filgrastim Injection Revenue Market Share by Region (2027-2032) Table 65. Teva Pharmaceuticals Company Information Table 66. Teva Pharmaceuticals Business Overview Table 67. Teva Pharmaceuticals Filgrastim Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceuticals Filgrastim Injection Product Portfolio Table 69. Teva Pharmaceuticals Recent Development Table 70. Novartis AG Company Information Table 71. Novartis AG Business Overview Table 72. Novartis AG Filgrastim Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novartis AG Filgrastim Injection Product Portfolio Table 74. Novartis AG Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Filgrastim Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Filgrastim Injection Product Portfolio Table 79. Pfizer Recent Development Table 80. Amgen Inc Company Information Table 81. Amgen Inc Business Overview Table 82. Amgen Inc Filgrastim Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Amgen Inc Filgrastim Injection Product Portfolio Table 84. Amgen Inc Recent Development Table 85. Accord Healthcare Company Information Table 86. Accord Healthcare Business Overview Table 87. Accord Healthcare Filgrastim Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Accord Healthcare Filgrastim Injection Product Portfolio Table 89. Accord Healthcare Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Filgrastim Injection Distributors List Table 93. Filgrastim Injection Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Filgrastim Injection Product Image Figure 2. Global Filgrastim Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgrastim Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Filgrastim Injection Sales (2021-2032) & (K L) Figure 5. Global Filgrastim Injection Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 Filgrastim Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 300mcg/0.5mL (Prefilled Syringe) Image Figure 9. 300mcg/mL (vial) Image Figure 10. 480mcg/0.8mL (Prefilled Syringe) Image Figure 11. 480mcg/1.6 mL (vial) Image Figure 12. Global Filgrastim Injection Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 13. Global Filgrastim Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Filgrastim Injection Sales Market Share by Type (2021-2032) Figure 15. Global Filgrastim Injection Revenue by Type (2021 VS 2025 VS 2032) & (K L) Figure 16. Global Filgrastim Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Filgrastim Injection Revenue Market Share by Type (2021-2032) Figure 18. Adult Use Image Figure 19. Pediatric Use Image Figure 20. Geriatric Use Image Figure 21. Global Filgrastim Injection Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 22. Global Filgrastim Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Filgrastim Injection Sales Market Share by Application (2021-2032) Figure 24. Global Filgrastim Injection Revenue by Application (2021 VS 2025 VS 2032) & (K L) Figure 25. Global Filgrastim Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Filgrastim Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 28. North America Filgrastim Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 30. Canada Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 31. Mexico Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 32. Europe Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 33. Europe Filgrastim Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 35. France Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 36. U.K. Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 37. Italy Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 38. Netherlands Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 39. Asia Pacific Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 40. Asia Pacific Filgrastim Injection Sales Market Share by Country (2021-2032) Figure 41. China Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 42. Japan Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 43. South Korea Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 44. Southeast Asia Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 45. India Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 46. Australia Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 47. South America, Middle East and Africa Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 48. South America, Middle East and Africa Filgrastim Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 50. South Africa Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 51. Saudi Arabia Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 52. Turkey Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 53. Argentina Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 54. UAE Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 55. Egypt Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 56. Chile Filgrastim Injection Sales and Growth Rate (2021-2032) & (K L) Figure 57. Global Filgrastim Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Filgrastim Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Filgrastim Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Filgrastim Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Filgrastim Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Filgrastim Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Filgrastim Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Filgrastim Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 300mcg/0.5mL (Prefilled Syringe)
  • 300mcg/mL (vial)
  • 480mcg/0.8mL (Prefilled Syringe)
  • 480mcg/1.6 mL (vial)
Applications
  • Adult Use
  • Pediatric Use
  • Geriatric Use
Companies covered
  • Teva Pharmaceuticals
  • Novartis AG
  • Pfizer
  • Amgen Inc
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Filgrastim Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Filgrastim Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Filgrastim Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Filgrastim Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Filgrastim Injection Market Dynamics
  1. 2.1 Filgrastim Injection Industry Trends
  2. 2.2 Filgrastim Injection Industry Drivers
  3. 2.3 Filgrastim Injection Industry Opportunities and Challenges
  4. 2.4 Filgrastim Injection Industry Restraints
3 Filgrastim Injection Market by Manufacturers
  1. 3.1 Global Filgrastim Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Filgrastim Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Filgrastim Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Filgrastim Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Filgrastim Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Filgrastim Injection Manufacturers, Product Type & Application
  7. 3.7 Global Filgrastim Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Filgrastim Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Filgrastim Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Filgrastim Injection Tier 1, Tier 2, and Tier 3
4 Filgrastim Injection Market by Type
  1. 4.1 Filgrastim Injection Type Introduction
  2. 4.1.1 300mcg/0.5mL (Prefilled Syringe)
  3. 4.1.2 300mcg/mL (vial)
  4. 4.1.3 480mcg/0.8mL (Prefilled Syringe)
  5. 4.1.4 480mcg/1.6 mL (vial)
  6. 4.2 Global Filgrastim Injection Sales by Type
  7. 4.2.1 Global Filgrastim Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Filgrastim Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Filgrastim Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Filgrastim Injection Revenue by Type
  11. 4.3.1 Global Filgrastim Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Filgrastim Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Filgrastim Injection Revenue Market Share by Type (2021-2032)
5 Filgrastim Injection Market by Application
  1. 5.1 Filgrastim Injection Application Introduction
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.1.3 Geriatric Use
  5. 5.2 Global Filgrastim Injection Sales by Application
  6. 5.2.1 Global Filgrastim Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Filgrastim Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Filgrastim Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Filgrastim Injection Revenue by Application
  10. 5.3.1 Global Filgrastim Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Filgrastim Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Filgrastim Injection Revenue Market Share by Application (2021-2032)
6 Global Filgrastim Injection Sales by Region
  1. 6.1 Global Filgrastim Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Filgrastim Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Filgrastim Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Filgrastim Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Filgrastim Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Filgrastim Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Filgrastim Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Filgrastim Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Filgrastim Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Filgrastim Injection Revenue by Region
  1. 7.1 Global Filgrastim Injection Revenue by Region
  2. 7.1.1 Global Filgrastim Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Filgrastim Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Filgrastim Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Filgrastim Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Filgrastim Injection Revenue (2021-2032)
  8. 7.2.2 North America Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Filgrastim Injection Revenue (2021-2032)
  11. 7.3.2 Europe Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Filgrastim Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Filgrastim Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Filgrastim Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Filgrastim Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Filgrastim Injection Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Filgrastim Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Filgrastim Injection Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Filgrastim Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Filgrastim Injection Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Amgen Inc
  20. 8.4.1 Amgen Inc Company Information
  21. 8.4.2 Amgen Inc Business Overview
  22. 8.4.3 Amgen Inc Filgrastim Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Inc Filgrastim Injection Product Portfolio
  24. 8.4.5 Amgen Inc Recent Developments
  25. 8.5 Accord Healthcare
  26. 8.5.1 Accord Healthcare Company Information
  27. 8.5.2 Accord Healthcare Business Overview
  28. 8.5.3 Accord Healthcare Filgrastim Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Accord Healthcare Filgrastim Injection Product Portfolio
  30. 8.5.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Filgrastim Injection Value Chain Analysis
  2. 9.1.1 Filgrastim Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Filgrastim Injection Production Mode & Process
  6. 9.2 Filgrastim Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Filgrastim Injection Distributors
  9. 9.2.3 Filgrastim Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst